53 related articles for article (PubMed ID: 23278563)
1. Diagnosis of invasive cutaneous squamous cell carcinoma, imaging and staging.
Dessinioti C; Liopyris K; Stratigos AJ
Ital J Dermatol Venerol; 2024 Apr; 159(2):118-127. PubMed ID: 38650493
[TBL] [Abstract][Full Text] [Related]
2. Patterns of major cutaneous surgeries and reconstructions in patients with cutaneous squamous cell carcinoma in the USA.
Chen CI; Jalbert JJ; Wu N; Ruiz ES
Future Oncol; 2024 Apr; 20(11):691-701. PubMed ID: 37994593
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.
Wang J; Harwood CA; Bailey E; Bewicke-Copley F; Anene CA; Thomson J; Qamar MJ; Laban R; Nourse C; Schoenherr C; Treanor-Taylor M; Healy E; Lai C; Craig P; Moyes C; Rickaby W; Martin J; Proby C; Inman GJ; Leigh IM
J Am Acad Dermatol; 2023 Dec; 89(6):1159-1166. PubMed ID: 37586461
[TBL] [Abstract][Full Text] [Related]
4. The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study.
Alexander MH; Cousins WJ; Ewen T; South AP; Lovat P; Stefanos N
J Cutan Pathol; 2024 Jun; 51(6):450-458. PubMed ID: 38421158
[TBL] [Abstract][Full Text] [Related]
5.
Zambrano-Román M; Padilla-Gutiérrez JR; Valle Y; Muñoz-Valle JF; Guevara-Gutiérrez E; López-Olmos PA; Sepúlveda-Loza LC; Bautista-Herrera LA; Valdés-Alvarado E
Biology (Basel); 2024 Mar; 13(3):. PubMed ID: 38534460
[TBL] [Abstract][Full Text] [Related]
6. Differences among oral carcinomas arising de novo from those associated with oral potentially malignant disorders: a systematic review and meta-analysis.
Piemonte ED; Gilligan GM; Garola F; Lazos JP; Panico RL; Normando AGC; Santos-Silva AR; Warnakulasuriya S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; ():. PubMed ID: 38609795
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the IHC Markers CD138 and CD43 in Oral Leukoplakia: An Original Research.
Akkaloori A; Saikia J; Kuppusamy A; Rana K; Dashatwar PD; Behura SS
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 1):S209-S212. PubMed ID: 37654342
[TBL] [Abstract][Full Text] [Related]
8. Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z; Chen S; Ying H; Yao W
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C29-C45. PubMed ID: 35584326
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1 (CD138), Carcinomas and EMT.
Couchman JR
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921767
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.
Kind S; Merenkow C; Büscheck F; Möller K; Dum D; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Göbel C; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Clauditz TS; Simon R; Sauter G; Wilczak W; Bawahab AA; Izbicki JR; Perez D; Marx A
Dis Markers; 2019; 2019():4928315. PubMed ID: 31976021
[TBL] [Abstract][Full Text] [Related]
11. Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior?
Alaeddini M; Yazdani F; Etemad-Moghadam S
Braz J Otorhinolaryngol; 2021; 87(2):171-177. PubMed ID: 31540870
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.
Szatmári T; Ötvös R; Hjerpe A; Dobra K
Dis Markers; 2015; 2015():796052. PubMed ID: 26420915
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.
Omar AA; Korvala J; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Sorsa T; Hagström J; Salo T
J Oral Pathol Med; 2015 Apr; 44(4):258-65. PubMed ID: 25047824
[TBL] [Abstract][Full Text] [Related]
14. MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Salo T; Sorsa T; Hagström J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):459-67. PubMed ID: 25697929
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
[TBL] [Abstract][Full Text] [Related]
16. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
18. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
